Synapse - Works

Results (2146)

A phase II randomized, double-blind trial of a polyvalent vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian (EOC), fallopian tube, or peritoneal cancer who are in second or third complete remission

Meeting Abstract

Sabbatini, P.; Chen, L. M.; Lucci, J. A.; Behbakht, K.; Spirtos, N. M.; Muller, C.; Benigno, B. B.; Powell, M. A.; Berry, E.; Tewari, K. S.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Peripheral blood T cell subset phenotype analysis in melanoma patients treated with combination nivolumab + ipilimumab compared to ipilimumab alone

Meeting Abstract

Postow, M. A.; Kuk, D.; Adamow, M.; Carrera, C.; Wong, P.; Curran, M. A.; Friedman, C. F.; Momtaz, P.; Shoushtari, A. N.; Wolchok, J. D.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Phase 1b of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with carboplatin (C) and paclitaxel (P) in recurrent platinum-sensitive ovarian cancer (OC)

Meeting Abstract

O'Cearbhaill, R. E.; McMeekin, D. S.; Mantia-Smaldone, G.; Gunderson, C.; Sabbatini, P.; Cattaruzza, F.; Fischer, M.; Kapoun, A. M.; Xu, L.; Dupont, J.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

IMGN853 (mirvetuximab soravtansine), a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC): Single-agent activity in platinum resistant epithelial ovarian cancer (EOC) patients (pts)

Meeting Abstract

Moore, K. N.; Martin, L. P.; Matulonis, U. A.; Konner, J. A.; Seward, S. M.; Bauer, T. M.; O'Malley, D. M.; Perez, R. P.; Jeong, W. D.; Zhou, Y. H.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Efficacy findings from a phase I safety study

Meeting Abstract

Lacouture, M. E.; Konner, J. A.; Stevens, J.; Brouwer, S.; Narain, N. R.; Ye, R.; Ravipaty, S.; Sarangarajan, R.; Akmaev, V. R.; Jimenez, J. J.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Predictors of unplanned hospitalizations among older adults receiving cancer chemotherapy

Meeting Abstract

Klepin, H. D.; Sun, C. L.; Smith, D. D.; Elias, R.; Trevino, K. M.; Bryant, A. L.; Nelson, C. J.; Tew, W. P.; Mohile, S. G.; Owusu, C.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

ADXS11-001 immunotherapy in squamous or non-squamous persistent/recurrent metastatic cervical cancer: Results from stage I of the phase II GOG/NRG0265 study

Meeting Abstract

Huh, W. K.; Dizon, D. S.; Powell, M. A.; Leath, C. A.; Landrum, L. M.; Tanner, E.; Higgins, R.; Ueda, S. M.; McHale, M. T.; Monk, B. J.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Toxicity associated with ipilimumab and nivolumab (Ipi plus Nivo) combination therapy in melanoma patients (pts) treated at a single-institution under an expanded-access program (EAP)

Meeting Abstract

Friedman, C. F.; Navid-Azarbaijani, P.; Shoushtari, A. N.; Campbell, S. C.; Callahan, M. K.; Momtaz, P.; Prempeh-Keteku, N. A.; Postow, M. A.; Shames, Y.; Wolchok, J. D.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Efficacy and safety of checkpoint blockade for treatment of advanced melanoma (mel) in patients (pts) age 80 and older (80+)

Meeting Abstract

Friedman, C. F.; Horvat, T. Z.; Minehart, J.; Panageas, K.; Callahan, M. K.; Chapman, P. B.; Momtaz, P.; Postow, M. A.; Shoushtari, A. N.; Wolchok, J. D.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Patient-reported outcomes from randomized, phase-3 study of trabectedin (T) vs. dacarbazine (D) in advanced Ieiomyosarcoma (LMS) or liposarcoma (LPS)

Meeting Abstract

Demetri, G. D.; von Mehren, M.; Jones, R. L.; Hensley, M. L.; Schuetze, S.; Elias, A. D.; Pierson, R. F.; Knoblauch, R. E.; Park, Y. C.; Wang, G. C.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save